Sanofi, GSK to seek authorization
for COVID-19 vaccine
|
|
Late-stage
trials found that two doses of the vaccine were about 58% effective in
preventing infection and 75% effective in preventing moderate to severe
disease, the companies said in a statement. |
Thursday, February 24, 2022
Sanofi, GSK to seek authorization for COVID-19 vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment